A listing of ctsi-central-admin medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
This pilot clinical trial studies how rituximab and latent membrane protein (LMP)-specific T-cells work in treating pediatric solid organ recipients with Epstein-Barr virus-positive, cluster of differentiation (CD)20-positive post-transplant lymphoproliferative disorder.
The purpose of this study is to understand, through getting your answers to questions on a survey, personal and community social network factors that lead to Mexican immigrants having trouble accessing and utilizing dental care, and features of anxiety associated with relocating to a new place to live.
The purpose of the study is to investigate the effects of different instructional conditions on Spanish language learning and the relationship between these instructional conditions and individual differences in learning.
The purpose of this study is to compare the effects good and/or bad of carboplatin with cisplatin on people with standard risk germ cell tumors to find out which is better.
This phase II trial studies how well cabozantinib-s-malate works in treating younger patients with sarcomas, Wilms tumor, or other rare tumors that have come back, do not respond to therapy, or are newly diagnosed.
68Ga-PSMA is a radiopharmaceutical used with PET imaging for the detection of prostate cancer under a compassionate IND in patients who have presented with biochemical failure. In this study, the use of 68Ga-PSMA-11 will be extended to newly diagnosed patients with high risk prostate cancer. Patients enrolled to this study …
The purpose of this study is to provide novel data to better elucidate the role of indoor exposure to Particulate matter 2.5 and ultra-fine particles (UFP) in the development of cardiovascular and respiratory diseases.
This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has come back or does not respond to treatment.